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Abstract
Introduction: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, also known as Hay-Wells
syndrome, is a rare genetic syndrome with ectodermal dysplasia. About 100 patients have been reported to
date. It is associated to a heterozygous mutation of the tumor protein p63 (TP63) gene, located on
chromosome 3q28. Typical clinical manifestations include: filiform ankyloblepharon adnatum (congenital
adherence of the eyelids), ectodermal abnormalities (sparse and frizzy hair, skin defects, nail alterations, dental
changes and hypohidrosis), and cleft lip/palate. Diagnostic suspicion is based on clinical signs and confirmed
by genetic testing.
Patient’s presentation: We hereby report on a female newborn with erythroderma, thin lamellar
desquamations, extensive skin erosions, sparse and wiry hair, filiform ankyloblepharon adnatum, agenesis of
the lachrymal puncta, cleft palate and nail dysplasia. Her phenotype was compatible with AEC syndrome.
Then, based on the clinical suspicion, sequencing analysis of the TP63 gene was performed, and revealed a
de novo novel missense mutation. Eyelids adherence and cleft palate underwent surgical correction, while
skin erosions were treated with topical antibiotics/antifungals and emollient/re-epithelizing creams. A surgical
reconstruction is presently planned for the agenesis of the lachrymal puncta. The infant currently is 17 months
of age and is included in a multidisciplinary follow-up. At present shows growth impairment and mild
developmental delay, and typical signs of ectodermal dysplasia with small areas of dermatitis lesions on the
scalp, without further abnormalities.
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Conclusions: Our report underlines the relevance of an early and careful clinical evaluation in neonates with
ankyloblefaron, facial dysmorphism, and signs of ectodermal dysplasia. In these cases, the suspicion of AEC
syndrome must be promptly raised, and sequencing analysis of TP63 early performed as well. An
individualized, multidisciplinary and long-term follow-up should be guaranteed to affected subjects and their
families, also to identify associated morbidities and prevent possible serious complications and adverse
outcomes.
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Introduction
Ankyloblepharon-ectodermal defects-cleft lip/palate
(AEC) syndrome, also known as Hay-Wells syndrome, is
a rare genetic disease, with about 100 patients reported
to date. The female/male ratio is 1:1 [1]. However, the
exact prevalence of the disease is unknown. AEC syn-
drome was first described by Hay and Wells in 1976 [2].
It belongs to ectodermal dysplasias (EDs), which are
birth defects affecting development and/or homeostasis
of two or more ectodermal derivatives, including hair,
teeth, nails, sweat glands, and skin [3].
AEC syndrome is associated to a heterozygous muta-
tion of the tumor protein p63 (TP63, MIM#603273)
gene, located on chromosome 3q28. Most reported vari-
ants induce an amino acid change in the sterile alpha
motif (SAM) domain of the encoded protein, disrupting
protein-protein interactions [4]. The disease shows an
autosomal dominant pattern of inheritance, with various
degree of expressivity. Sporadic cases have been reported
[5]. Clinical manifestations, typically present at birth, in-
clude: filiform ankyloblepharon adnatum (congenital ad-
herence of the eyelids), ectodermal abnormalities (sparse
and frizzy hair, skin defects, nail alterations, dental
changes and hypohidrosis), and cleft palate and/or lip
[6]. Diagnostic suspicion is based on clinical signs and
confirmed by genetic testing.
We report on a female newborn with phenotype com-
patible with AEC syndrome, with a de novo missense
mutation of the TP63 gene. Our study highlights the
relevance of an early and careful clinical evaluation in
case of patients with EDs and/or TP63-related congenital
disorders.
A prompt diagnosis may be also useful for an appro-
priate genetic counselling and management of AEC syn-
drome patients. Multidisciplinary and long-term follow-
up of these subjects must be oriented to manage and
anticipate the needs related to the associated morbidities,
as well as to avoid or lower possible adverse outcomes.
Patient’s presentation
A female newborn, first child of healthy and non-
consanguineous parents, was born at term by vaginal de-
livery. Pregnancy was marked by gestational hypertension,
treated with acetylsalicylic acid, and well controlled dia-
betes. Apgar scores were 9 and 10, at 1 and 5minutes re-
spectively. At birth, anthropometric measures were as
follows: weight 2780 g (21st centile), length 47 cm (16th
centile) and occipitofrontal circumference (OFC) 33 cm
(29th centile). Due to cleft palate and dysmorphic features,
she was transferred, on the first day of life, from a first
level birthing center to our Neonatal Intensive Care Unit.
At admission, physical examination showed erythroderma,
thin lamellar desquamations, extensive skin erosions on
the back, hands and gluteal region, sparse and wiry hair,
filiform ankyloblepharon adnatum, cleft palate, and nail
dysplasia. Cupped ears, maxillary hypoplasia, broad nasal
root, short philtrum, microstomia, thin lips, and micro-
glossia outlined her craniofacial profile (Fig. 1a/b). Hypo-
plasia of the left distal phalange of the 2nd finger, and
widely spaced nipples were also observed. Her clinical
course was characterized by initial feeding difficulties,
from which she rapidly recovered. However, due to large
transdermal losses, especially in the scalp, intravenous hy-
dration was needed for the first days of life. In the mean-
time, a treatment with topical antibiotics/antifungals and
emollient/re-epithelizing creams was started. The skin
picture progressively improved with resolution of the
erosions on the back, hands and gluteal region, as well as
of nail dysplasia, with persistence of erythematous
seborrheic-like lesions in the scalp (Fig. 2a). On the 10th
day of life, our newborn underwent surgical excision of
the fibrous adhesions of eyelids, without complications.
Ophthalmological evaluation resulted normal. Laboratory
analyses including complete blood count, serum electro-
lytes, liver, kidney and thyroid function tests showed nor-
mal results. Head, heart, and abdominal ultrasound (US),
as well as hearing screening, were normal. Then, based on
the clinical suspicion of a TP63-related disorder, sequen-
cing analysis of TP63 was performed, and revealed a mis-
sense heterozygous mutation in exon 13, causing the
amino acid substitution of isoleucine for threonine at pos-
ition 576 (p.Ile576Thr, c.1727 T > C). This variant has not
hitherto been reported and described in the literature.
Gene sequencing was extended to the parents. They re-
sulted normal, confirming the de novo origin of the new
mutation. Based on the clinical and genetic findings, a
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diagnosis of AEC syndrome was made. The newborn was
discharged at 1month of age in good general conditions
and adequate weight and length growth, and included in a
multidisciplinary (ophthalmological, dermatological, surgi-
cal, odontostomatological and neurodevelopmental)
follow-up. Cleft palate was surgically repaired at age 15
months. Due to abnormal tongue position, a speech ther-
apy was also begun. Owing to repeated episodes of con-
junctivitis, a further ophthalmological evaluation disclosed
agenesis of the lachrymal puncta, for which a surgical re-
construction has been planned. She currently is 17months
and 21 days of age, and her anthropometric measures are:
weight 8400 g (6th centile), length 74.5 cm (2nd centile)
and OFC 44.6 cm (13th centile) (according to the World
Health Organization growth chart for neonatal and infant
close monitoring) [7]. The infant still needs topical treat-
ment with emollient and re-epithelizing creams. Small
areas of dermatitis lesions with erosions, crusts and scar-
ring alopecia persist on the scalp (Fig. 2b). Hair, eyebrows
and eyelashes are sparse. Nails are thin and dystrophic.
Oligodontia and conical teeth are also observed. A devel-
opmental delay completes her clinical profile. She has a
mild cognitive and language impairment, normal muscu-
lar tone and reflexes, and regular acquisition of neuromo-
tor milestones. At present she shows no further
abnormalities.
Discussion and conclusions
AEC syndrome belongs to EDs, which are birth defects
affecting the development of hair, teeth, nails, sweat
glands, and other ectodermal structures [3, 8]. Most
clinical features are evident from birth, such as filiform
ankyloblepharon adnatum, ectodermal anomalies and
cleft palate and/or lip. All of them were observed in our
newborn. Indeed, ankyloblepharon is present in 70% of
affected neonates. Its severity can vary from complete
fusion of the eyelids, to partial fusion, or even a dimin-
ished palpebral fissure length [9]. Other ophthalmo-
logical defects may be present, such as agenesis or
atresia of the lachrymal puncta, often leading to chronic
Fig. 1 a Front view. Broad nasal root, short philtrum, microstomia and thin lips. b Lateral view. Sparse and wiry hair, cupped ears and
maxillary hypoplasia
Fig. 2 Skin lesions on the scalp, before (a) and after (b) long term treatment with emollient/re-epithelizing creams
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conjunctivitis and/or blepharitis, as in our patient. Ecto-
dermal anomalies may include skin, hair, nail, dental and
sweating abnormalities. A classic erythrodermic presen-
tation with peeling skin and superficial erosions is com-
mon, resulting in potentially fatal infections due to acute
skin failure. The erosions more typically affect the scalp:
they may be present at birth or develop during infancy.
The more severe scalp erosions often lead to scarring
alopecia and hypotrichosis. Most affected patients have
nail dystrophy and dental abnormalities, including hypo-
dontia and conical teeth [10, 11]. Sweating may be de-
creased, with resultant thermal intolerance [12]. Cleft
palate with or without cleft lip occurs in all AEC syn-
drome patients. Conversely, rare clinical findings include
ear canal atresia, supernumerary nipples, limb anomalies,
hypospadias, and heart defects [6, 13]. The differential
diagnoses should include ichthyosis and epidermolysis
bullosa, from which, however, AEC syndrome is distin-
guished by the type of skin lesions, and the occurrence of
eye alterations and cleft lip/palate. Moreover, TP63-related
disorders, belonging to EDs syndromes, should also be
considered as possible differential diagnosis. These syn-
dromes include ectrodactyly-ectodermal dysplasia-cleft
lip/palate (EEC, MIM#129900) syndrome, Rapp-Hodgkin
syndrome (MIM#603273), acro-dermo-ungual-lacrimal-
tooth (ADULT, MIM#103285) syndrome, split hand/foot
malformation type 4 (SHFM4, MIM#605289), limb-
mammary syndrome (LMS, MIM#603543) and orofacial
cleft 8 (OFC8, MIM#618149) [14, 15].
Then, AEC syndrome diagnosis must be suspected
based on suggestive clinical findings, and confirmed by
sequencing analysis of TP63. The disease shows an auto-
somal dominant pattern of transmission. Approximately
30% of patients have an affected parent, while 70% have
a de novo TP63 pathogenetic variant [16]. TP63, located
on chromosome 3 (3q28), is a homologue of the TP53
tumor suppressor gene, encoding for the p63 protein, a
member of a family of transcription factors involved in
regulating both proliferation and differentiation of the
epidermal keratinocytes. Multiple transcription factors
produced by TP63 are different in the N-terminal, and
C-terminal domains (α, β, γ or δ isoforms), and identical
in the central DNA-binding one (DBD) [17, 18]. Only
the α isoforms contain a sterile alpha motif (SAM) do-
main, followed by a transactivation inhibitory (TI) do-
main, which is able to auto-inhibit the transcriptional
activity. These latter domains are involved in protein-
protein interaction processes.
TP63 gene mutations have highly pleomorphic effects,
and genotype-phenotype correlations for TP63-related
disorders are gradually becoming clear [19]. To date, mis-
sense and frameshift mutations in exons 13 and 14, which
encode, indeed, for the SAM and TI domains, account for
the vast majority of mutations [20]. Moreover, such
mutations are associated to increased amino acid change
ratio, leading to aberrant splicing of the p63 protein, and
to altered interaction with the keratinocyte growth factor
receptor. This may affect, in turn, proliferation, differenti-
ation and survival of epidermal cells, and it may be the
underlying pathogenetic molecular mechanism respon-
sible for many clinical findings of the disease [21].
Here we report on a TP63 variant, which has not been
previously reported and described in the literature. This
novel missense mutation, located in the α C-terminus re-
gion of the encoded protein and containing a SAM do-
main, may be deleterious and cause the clinical picture of
present patient. The phenotype of our newborn matches,
indeed, that of TP63-related disorders. The pathogenicity
of this de novo variant is, moreover, supported by the ab-
sence of disease in the other family members.
Further molecular and functional studies will allow to
elucidate the structure-function relationship of the p63
protein and to identify its downstream targets. This, in
turn will lead to a better characterization of the disease
and to clarify the genotype-phenotype correlations in
TP63-related syndromes.
An early diagnosis of AEC syndrome is crucial in
order to implement appropriate genetic counseling to
parents, to define their genetic profile and to identify, as
early as possible, those who would benefit from primary
and/or secondary prevention of disease [22]. It is neces-
sary to provide update and complete information on po-
tential risks to offspring, and on reproductive options to
young adults who are affected or at risk. Once the TP63
pathogenetic variant has been identified in an affected
family member, prenatal and/or preimplantation genetic
testing are possible.
A multidisciplinary approach (pediatrician, dermatolo-
gist, odontostomatologist, pediatric surgeon, ophthal-
mologist, geneticist, speech therapist) to AEC syndrome
patients includes treatments aimed to avoid associated
morbidities and their complications, such as infections.
It is also necessary to evaluate and promote growth, de-
velopment, and psycho-social integration of affected sub-
jects [23, 24]. Indeed, after the period of early childhood,
when the risk of serious complications like infections
and/or loss of fluids is increased, the general prognosis
of patients is good with a normal life expectancy.
Our report highlights the relevance of an early and care-
ful clinical evaluation in neonates with ankyloblefaron, fa-
cial dysmorphisms, and signs of ectodermal dysplasia. In
these cases, the suspicion of AEC syndrome must be
promptly raised, and sequencing analysis of TP63 early
performed as well. An individualized, multidisciplinary
and long-term follow-up should be guaranteed to affected
subjects and their families, aimed at identifying associated
morbidities and preventing and/or lowering possible ser-
ious complications and adverse outcomes [25–27].
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